Rx-Strength Luxamend Decreases Average Healing Time For Wounds3,4

Rx-Strength Luxamend Decreases Average Healing Time For Wounds3,4

Before & After Treatment

BASELINE

DAY 5

Shave Biopsy (Forearm)
Treated With Luxamend

Male, 48 Years Old. Results May Vary.

BASELINE

WEEK 3

WEEK 6

Mohs Surgical Wound
Treated With Luxamend

Male, 63 Years Old. Results May Vary.

Mohs Surgical Wound
Treated With Luxamend

Male, 63 Years Old. Results May Vary.

BASELINE

WEEK 3

WEEK 6

BASELINE

DAY 9

DAY 22

Left Hand Trauma
Treated With Luxamend

Male, 32 Years Old. Results May Vary.

Left Hand Trauma
Treated With Luxamend

Male, 32 Years Old. Results May Vary.

BASELINE

DAY 9

DAY 22

BASELINE

DAY 5

Thermal Wounds
Treated With Luxamend

Female, 21 Years Old. Results May Vary.

BASELINE

DAY 32

DAY 105

Lower Leg Wound
Treated With Luxamend

Male, 70 Years Old. Results May Vary.

Lower Leg Wound
Treated With Luxamend

Male, 70 Years Old. Results May Vary.

BASELINE

DAY 32

DAY 105

Find A Pharmacy Near You That Dispenses Luxamend

Find A Pharmacy Near You That Dispenses Luxamend

Important Safety Information

Indications and Usage

Luxamend® is indicated for use in:

  • Full Thickness Wounds, Pressure Sores, Dermal Ulcers including Lower Leg Ulcers
  • Superficial Wounds
  • 1st and 2nd Degree Burns, including Sunburns
  • Dermal Donor and Graft Site Management
  • Radiation Dermatitis
  • Minor Abrasions

Contraindications

Luxamend is contraindicated for use on bleeding wounds, skin rashes related to food or medicine allergies, and when an allergy to one of the ingredients is known.

Warnings

  • In radiation therapy, Luxamend may be applied as directed by the treating physician. Do not apply 4 hours prior to a radiation session.
  • Do not apply Luxamend to dermal grafts until after the graft has successfully taken.
  • Keep out of the reach of children.

Precautions

  • For the treatment of any dermal wound, consult a physician. Use Luxamend only as directed.
  • Luxamend does not contain a sunscreen and should not be used prior to extended exposure to the sun.
  • The use of Luxamend on skin rashes due to allergies has not been studied sufficiently and therefore is not recommended.
  • If clinical signs of infection are present, appropriate treatment should be initiated. If clinically indicated, use of Luxamend may be continued during the anti-infective therapy.
  • If condition does not improve within 10-14 days, consult a physician.

Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of medical products to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for Full Prescribing Information.

REFERENCES:
1. LUXAMEND® Prescribing Information. Journey Medical Corporation, Scottsdale, AZ, 2023.
2. Symphony Health Solutions PHAST IDV Monthly TRx Data 2016 – 2018 (TRx market data includes: Biafine®, Sonafine®, Bionect®, Prutect™, Avo Cream™).
3. Cohen JL, Lorizzo JL and Kircik LH. Use of a topical emulsion for wound healing. 2007. J Support Oncol. 10 Suppl 5:1-9.
4. Del Rosso, JQ. Healing Wounds After Cryotherapy. 2007. The Dermatologist. Accessed at http://www.the-dermatologist.com/article/7144. Access date: 10/9/2015.
5. Kircik, LH. Study of Trolamine-Containing Topical Emulsion for Wound Healing after Shave Biopsy. 2009. Cutis. 83:326-332.

Luxamend is a registered trademark of Journey Medical Corporation.
All rights reserved. ©2023 Journey Medical Corporation. August 2023 LUX-M02-R00